Lexicon Pharmaceuticals
LXRX
LXRX
108 hedge funds and large institutions have $214M invested in Lexicon Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 113 → 108 (-5)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Holders
108
Holding in Top 10
3
Calls
$258K
Puts
$158K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$1.98M | |
| 3 | +$1.61M | |
| 4 |
Lazard Asset Management
New York
|
+$1.51M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.17M |
Top Sellers
| 1 | -$2.6M | |
| 2 | -$1.44M | |
| 3 | -$818K | |
| 4 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
-$479K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$476K |